↓ Skip to main content

Dove Medical Press

A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects

Overview of attention for article published in Drug Design, Development and Therapy, February 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
58 Mendeley
Title
A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects
Published in
Drug Design, Development and Therapy, February 2015
DOI 10.2147/dddt.s75980
Pubmed ID
Authors

Sang-In Park, Howard Lee, Jaeseong Oh, Kyoung Soo Lim, In-Jin Jang, Jeong-Ae Kim, Jong Hyuk Jung, Kyung-Sang Yu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 2%
Unknown 57 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 14%
Other 7 12%
Student > Bachelor 7 12%
Student > Ph. D. Student 4 7%
Researcher 3 5%
Other 9 16%
Unknown 20 34%
Readers by discipline Count As %
Medicine and Dentistry 13 22%
Nursing and Health Professions 7 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Biochemistry, Genetics and Molecular Biology 4 7%
Agricultural and Biological Sciences 4 7%
Other 4 7%
Unknown 21 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#8,533,995
of 25,371,288 outputs
Outputs from Drug Design, Development and Therapy
#642
of 2,268 outputs
Outputs of similar age
#112,025
of 361,157 outputs
Outputs of similar age from Drug Design, Development and Therapy
#18
of 62 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,157 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.